Finance

Lists
600223:SHA
Lushang Freda Pharmaceutical Co Ltd
CN¥5,71
+1,42%
(+0,080) 1D
16 Okt., 11:29:46 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600223...
Open
CN¥5,70
High
CN¥5,76
Low
CN¥5,67
Mkt. cap
5,81 mjd
Avg. vol.
7,60 m
Volume
4,29 m
Dividend
1,00%
Quarterly dividend
CN¥0,01
Ex-dividend date
15 Jul. 2026
P/E ratio
35,93
52-wk high
CN¥8,37
52-wk low
CN¥4,89
EPS
CN¥0,16
Shares outstanding
1,00 mjd
No. of employees
4 k
Open
CN¥5,70
High
CN¥5,76
Low
CN¥5,67
Mkt. cap
5,81 mjd
Avg. vol.
7,60 m
Volume
4,29 m
Dividend
1,00%
Quarterly dividend
CN¥0,01
Ex-dividend date
15 Jul. 2026
P/E ratio
35,93
52-wk high
CN¥8,37
52-wk low
CN¥4,89
EPS
CN¥0,16
Shares outstanding
1,00 mjd
No. of employees
4 k
News stories
From web sources and news partners
About Lushang Freda Pharmaceutical Co Ltd
CEO-
Employees3,51 k
Founded21 Apr. 1993
Headquarters-
SectorPersonal care products
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
807,27 m
1,05 mjd
900,44 m
1,01 mjd
Cost of goods sold
405,63 m
471,27 m
396,42 m
421,75 m
Cost of revenue
405,63 m
471,27 m
396,42 m
421,75 m
Research and development expenses
36,89 m
45,66 m
36,86 m
48,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
341,03 m
474,78 m
430,50 m
473,99 m
Operating expense
374,09 m
533,36 m
480,80 m
539,54 m
Total operating expenses
779,72 m
1,00 mjd
877,22 m
961,29 m
Operating income
27,55 m
49,45 m
23,22 m
47,58 m
Other non operating income
1,07 m
-957,33 k
-791,85 k
-5,62 m
EBT including unusual items
48,93 m
82,80 m
43,83 m
72,63 m
EBT excluding unusual items
57,55 m
64,40 m
43,79 m
64,06 m
Income tax expense
4,84 m
23,67 m
6,31 m
8,27 m
Effective tax rate
9,90%
28,59%
14,40%
11,39%
Other operating expenses
-7,23 m
19,88 m
5,68 m
11,18 m
Net income
33,78 m
46,01 m
31,90 m
49,88 m
Net profit margin
4,18%
4,36%
3,54%
4,94%
Earnings per share
-
-
-
-
Interest and investment income
29,41 m
17,70 m
21,99 m
23,61 m
Interest expense
-
-2,08 m
-629,37 k
-711,25 k
Net interest expenses
29,41 m
15,63 m
21,36 m
22,90 m
Depreciation and amortization charges
-
-
-
-
EBITDA
50,97 m
75,36 m
49,13 m
73,66 m
Gain or loss from assets sale
37,48 k
55,90 k
-
-78,27 k
AI content may include mistakes. Learn more
Google-programme